We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stericycle Completes Sale of Domestic Environmental Solutions
Read MoreHide Full Article
Stericycle, Inc.(SRCL - Free Report) yesterday announced that it has completed the divestiture of the Domestic Environmental Solutions business to Harsco Corporation for nearly $462.5 million in cash. The deal was initially announced on Feb 7, 2020.
Deal Details & Benefits
The deal includes Stericycle’s Manufacturing and Industrial Services and the retail portion of Hazardous Waste Services, which together employ nearly 2,000 team members across 61 facilities.
Operations of Stericycle’s regulated medical waste and secure information destruction businesses will not be hampered by this sale. The company plans to utilize the net proceeds from the sale to pay off its outstanding debt.
The company will continue offering solutions for unused consumer pharmaceutical take-back services and provide hazardous waste services to healthcare customers as an integrated services provider. Also, it has subcontracted with Harsco to perform hazardous waste services, which includes collection, transportation and disposal as per requirements.
Notably, Cindy J. Miller, CEO of Stericycle, stated, "The sale of the Domestic Environmental Solutions business is the sixth divestiture we have completed over the last 15 months and demonstrates important progress in our transformation as we focus on our core business, reduce debt, enhance our balance sheet flexibility, and drive long-term shareholder value.”
Previously, as part of the portfolio rationalization strategy within Business Transformation, Stericycle completed five divestitures — operations in Chile, the U.K.-based texting business, the North American telephone answering services business, a retail pharmaceutical returns business and all of its Mexican operations — in 2019. Overall, the company earned almost $83.7 million in gross proceeds from these transactions during 2019.
Zacks Rank & Stocks to Consider
Currently, Stericycle carries a Zacks Rank #3 (Hold).
Long-term expected EPS (three to five years) growth rate for Booz Allen Hamilton and Charles River Associates is 11.9% and 13%, respectively.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
Image: Bigstock
Stericycle Completes Sale of Domestic Environmental Solutions
Stericycle, Inc.(SRCL - Free Report) yesterday announced that it has completed the divestiture of the Domestic Environmental Solutions business to Harsco Corporation for nearly $462.5 million in cash. The deal was initially announced on Feb 7, 2020.
Deal Details & Benefits
The deal includes Stericycle’s Manufacturing and Industrial Services and the retail portion of Hazardous Waste Services, which together employ nearly 2,000 team members across 61 facilities.
Operations of Stericycle’s regulated medical waste and secure information destruction businesses will not be hampered by this sale. The company plans to utilize the net proceeds from the sale to pay off its outstanding debt.
The company will continue offering solutions for unused consumer pharmaceutical take-back services and provide hazardous waste services to healthcare customers as an integrated services provider. Also, it has subcontracted with Harsco to perform hazardous waste services, which includes collection, transportation and disposal as per requirements.
Notably, Cindy J. Miller, CEO of Stericycle, stated, "The sale of the Domestic Environmental Solutions business is the sixth divestiture we have completed over the last 15 months and demonstrates important progress in our transformation as we focus on our core business, reduce debt, enhance our balance sheet flexibility, and drive long-term shareholder value.”
Previously, as part of the portfolio rationalization strategy within Business Transformation, Stericycle completed five divestitures — operations in Chile, the U.K.-based texting business, the North American telephone answering services business, a retail pharmaceutical returns business and all of its Mexican operations — in 2019. Overall, the company earned almost $83.7 million in gross proceeds from these transactions during 2019.
Zacks Rank & Stocks to Consider
Currently, Stericycle carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Business Services sector are Booz Allen Hamilton (BAH - Free Report) and Charles River Associates (CRAI - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Long-term expected EPS (three to five years) growth rate for Booz Allen Hamilton and Charles River Associates is 11.9% and 13%, respectively.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>